Senior executives and a larger owner in CLS (directly or through companies), as described below, exercise, pro rata, warrants of series TO 6 B for a total of approximately
Hans von Celsing (Chairman) - 800,000 TO 6 B, corresponding to approx.SEK 80 thousand -
Dan J Mogren (CEO) - 315,960 TO 6 B, corresponding to approx.
SEK 31.6 thousand Khattar Holdings Pte Ltd - 5,952,375 TO 6 B, corresponding to approx.SEK 595 thousand
In order for the warrants not to expire worthless, the holder must subscribe for new B-shares, with the support of warrants, no later than
Information brochures about the Company and the offer (in Swedish and English) and other material for investors are available on CLS, Sedermera Corporate Finance AB's, Redeye AB's and Nordic Issuing AB's respective websites (www.clinicallaser.se, www.sedermera.se, www.redeye.se, www.nordic-issuing.se). Complete terms and conditions and instructions for warrants of series TO 6 B are available on the Company's website.
Advisors
In connection with the exercise of warrants of series TO 6 B,
For more information about the warrants of series TO 6 B, please contact:
Phone: +46 40 615 14 10
E-mail: cf@sedermera.se
Website: www.sedermera.se
Phone: +46 (0)8 545 013 30
E-mail: info@redeye.se
Website: www.redeye.se
For more information about CLS, please contact:
Dan J Mogren, CEO,
Phone: +46 (0) 70-590 11 40
E-mail: dan.mogren@clinicallaser.com
Website: www.clinicallaser.se
This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.
About CLS
For more information about CLS, please visit the Company's website: www.clinicallaser.se
https://news.cision.com/cls/r/senior-executives-and-larger-owner-exercise--pro-rata--warrants-of-series-to-6-b-for-approximately-s,c3916511
https://mb.cision.com/Main/11591/3916511/2565495.pdf
(c) 2024 Cision. All rights reserved., source